CD300LD

protein-coding

CD300 molecule like family member d, the group of V-set domain containing

Gene summary

Predicted to enable transmembrane signaling receptor activity and virus receptor activity. Predicted to be involved in immune response-activating signaling pathway. Predicted to act upstream of or within regulation of interleukin-6 production and regulation of tumor necrosis factor production. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]

MANE transcript

NM_001115152.2

Inheritance

—

ClinVar variants

U:29B:3

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 0.88

Max pathogenic AF

—

Genomic locus

chr17:74,579,365-74,592,283

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~12.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

No GenCC data available for this gene.

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CD300LD variants in ClinVar

2 Conditions Cataloged
not specifiedTotal: 31
not providedTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001115152.2. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
missense
29
clinvar
2
clinvar
31
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total00293032
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 3 of 3 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001115152.2RefSeqNP_001108624.14MANE Select
ENST00000375352.1EnsemblENSP00000364501.14MANE Select
XM_047435046.1RefSeqXP_047291002.13Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Immune System
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Adaptive Immune System

Biological Process

  • immune system process
  • regulation of immune response

Molecular Function

  • protein binding

Cellular Component

  • plasma membrane
  • integral component of membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000375352
Coding exons
4
Length
12919
Individuals with no LoFs
124916
Homozygous LoFs
0
Heterozygous LoFs
15
Defined
124931
p
0.0000600
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.119981010.9670.000004991237
Missense (PolyPhen)2623.6411.0998305
Synonymous-0.8995042.51.180.00000231398
Loss of Function0.32489.050.8844.53e-799

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000130.00013rare
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian0.000500.00049rare
Finnish00.0absent
European (Non-Finnish)0.0000270.000027rare
South Asian0.0000350.000033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Intolerance Scores

LoFtool
0.404
RVIS EVS
0.31
RVIS percentile EVS
72.23

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.0940

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.